Publicaciones en las que colabora con Borja Barrera Cuesta (10)

2015

  1. ABCG2/BCRP interaction with the sea grass Thalassia testudinum

    Drug Metabolism and Personalized Therapy, Vol. 30, Núm. 4, pp. 251-256

  2. Short communication: The gain-of-function Y581S polymorphism of the ABCG2 transporter increases secretion into milk of danofloxacin at the therapeutic dose for mastitis treatment

    Journal of Dairy Science, Vol. 98, Núm. 1, pp. 312-317

2014

  1. Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain

    Pharmacological Research, Vol. 87, pp. 87-93

2013

  1. Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: Role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter

    Veterinary Journal, Vol. 198, Núm. 2, pp. 429-436

  2. Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: Effect on plasma and milk levels of danofloxacin in sheep

    Veterinary Journal, Vol. 196, Núm. 2, pp. 203-208

2012

  1. Reevaluation of the roles of ABCG2 in the disposition of genistein

    Drug Metabolism and Disposition

  2. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3535-3543

2011

  1. Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice

    Drug Metabolism and Disposition, Vol. 39, Núm. 11, pp. 2008-2012

  2. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: Interaction with ivermectin

    Journal of Veterinary Pharmacology and Therapeutics, Vol. 34, Núm. 4, pp. 313-321

  3. The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system

    Pharmacological Research, Vol. 64, Núm. 4, pp. 359-363